Free HCV Train-the-Trainer Workshop

ISSUE NUMBER  Thirty-Seven• August 2017

dividerAdult Viral Hepatitis prevention programdivider

Free HCV Train-the-Trainer Workshop in Allen County

On September 28th, join the Hepatitis C Support Project as it presents the Hepatitis C Train-the-Trainer Workshop in Ft. Wayne, IN.

Who Should Attend?

Health educators, HIV/STD counselors and testers, medical providers, substance abuse counselors, case managers, support group leaders, corrections and law enforcement, people living with HCV and other health professionals who will provide education, support and advocacy for people and populations affected by HCV

After this workshop, attendees will be able to:

• Explain transmission, prevention, symptoms and treatments for hepatitis C

• Explain basic information regarding hepatitis C

• Describe the various tests used in diagnosing hepatitis C

• Contrast between acute and chronic hepatitis C and describe possible long-term liver damage.

• Identify various methods helpful in managing hepatitis C

• Describe current medical treatments and the side effects

• Communicate a plan of action of how to educate and support others in your community about hepatitis C

• Learn about local resources

Please click the link below to register.

Contact Sherika Sides at for questions.


8th Annual Prescription Drug Abuse and Heroin Symposium

The Attorney General's office is pleased to announce that registration is now open for the 8th Annual Rx Symposium. Attendees will be provided the opportunity to network with 550 professionals from local, state, and federal agencies, business, academia, clinicians, treatment providers, counselors, educators, state and national leaders, and advocates impacted by Rx drug abuse and heroin use. Tickets for the 1 ½ day program are $50 until September 1st and thereafter $75.  

Sheraton Hotel, Keystone at the Crossing,

Indianapolis, IN
October 30 - 31, 2017

CLICK HERE TO REGISTER and view the agenda and hotel information.


FDA Approved Two New Hepatitis C Treatments


On August 3rd, the U.S. Food and Drug Administration (FDA) approved AbbVie's Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus genotypes 1-6 without cirrhosis or with mild cirrhosis. It is the first treatment of eight weeks duration approved for all 6 major hepatitis C virus genotypes in adult patients without cirrhosis who have not been previously treated.

Trials including approximately 2,300 adults with genotype 1,2.3,4,5 or 6, demonstrated that 92-100 percent of patients had no virus detected in the blood 12 weeks after completing treatment.

The wholesale acquisition cost for Mavyret is $26,400 for 8 weeks and $39,600 for 12 weeks of treatment.


On July 18th, the FDA approved Gilead's Vosevi. The treatment includes sofosbuvir, velpatasvir and a new drug, voxilaprevir. Vosevi treats adults with chronic hepatitis c virus genotypes 1-6 without cirrhosis or mild cirrhosis. It is the first treatment for approved for patients who have been previously treated with sofosbuvir or other drugs for HCV that inhibit a protein call NS5A.

Two trials demonstrated that 96-97 percent of patients who received the treatment had no virus detected in the blood 12 weeks after finishing treatment.

The wholesale acquisition cost for Vosevi is $74,760 for 12 weeks treatment.


Hepatitis C Public Health Detailing Kit for Local Health Departments

The National Association of County and City Health Officials (NACCHO) released its Hepatitis C Public Health Detailing kit on World Hepatitis Day, July 28th.

Local health department efforts are critical to increasing screening, diagnosis, and linkage to care; however, they cannot do it alone. Partnering with healthcare providers is vital, and public health detailing is an important strategy for increasing provider awareness and building provider capacity to address HCV. Public health detailing uses short in-person visits with providers to deliver key messages and essential information on treating and preventing diseases and conditions impacting local communities.

To support local health departments to conduct provider detailing for HCV, NACCHO developed a Hepatitis C Public Health Detailing Kit, which is now available to download. The Detailing Kit is a collection of tools and resources local health departments can use in implementing public health detailing as a strategy to increase healthcare provider awareness and uptake of effective practices for HCV screening, diagnosis, and linkage to care and treatment.

Download the Hepatitis C Public Health Detailing Kit here:



Stats Explorer

Visitors to the Stats Explorer website can find information about the prevalence of drug overdoses, sexually transmitted diseases, births and deaths, cancer, infectious diseases and many other health issues, all in one convenient location. Previously, the data were available through multiple pages on the ISDH website.

Diseases and conditions provided in Stats Explorer can be viewed as counts or rates for various time periods. Data can be displayed in a variety of formats, including charts and maps, with the click of a button. 

To use Stats Explorer, go to From the drop-down menu, select one of many different public health categories to find detailed data published by ISDH and other partners.


The CDC has released AtlasPlus, a tool that gives users the ability to create tables, maps, and charts using over 15 years of HIV, viral hepatitis, STD, and TB surveillance data. AtlasPlus offers significant upgrades from the original version of Atlas including:

  • Easy, quick access to the latest data by county, state, or U.S. total;
  • 2015 data for HIV, STDs, TB and viral hepatitis
  • An upgrade to the Tables function (Based on user feedback, we made it more intuitive to build tables based on the exact subset of the data you want to view.);
  • Improved chart capabilities such as line graphs by year, bar charts by states or counties, pie charts for sex, bar charts for age, race/ethnicity, transmission category (HIV), country of birth (TB);
  • New ability to create two side-by-side maps or charts, e.g., compare two diseases, two race/ethnicity groups, or two age groups; and 
  • Mobile access

Click here to visit the page.

HepCure Toolkit

The HepCure Toolkit is a free online support resource for hepatitis C providers and patients. The toolkit is comprised of three different components: a weekly tele-education webinar series, provider dashboard, and a patient app.

The Tele-Education Webinar Series is held every Tuesday from 4:30 PM - 5:30 PM EST and features many topics in hepatitis C. Continuing education credits (CME/CNE) are offered through attendance of the webinars. All of the webinars are archived for playback or download on HepCure's Tumblr page.

For further details, click here.


divider divider